XBP Global Holdings, Inc. Reports Second Quarter 2026 Financial Results

XBP Global Holdings, Inc. (XBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ XBP Global Holdings, Inc. Reports Second Quarter 2026 Financial Results August 13, 2026 IRVING, TX, August 13, 2026 (GLOBE NEWSWIRE) – XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchest

Event · Earnings
Also in this documentGuidance · raise · $65M–$75M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Aug 13, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$XBP
Bullish
medium confidence
Mentioned
$XBP
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$XBPBullishMed
01

Why it matters

Key tradable items are the profitability step-up (Normalized EBITDA and adjusted gross margin), the raised annualized operational efficiency target from $55-$60M to $65-$75M, and commercial momentum via TCV and ACV closures, alongside revenue decline and a reported net loss.

02

Market read

This is a same-day earnings release via SEC filing with fresh margin and efficiency guidance that can drive near-term positioning ahead of the earnings call.

03

What to watch

TCV and ACV strength is highlighted, but the filing does not provide GAAP EPS, cash flow, or backlog conversion details here; traders may discount the guidance raise until cash generation and contract timing are clearer.

Relevance 7/10Novelty 8/10Timing: after-hours filing today, before/into the Aug 13 earnings call

Background

SEC 8-K Item 2.02 with Exhibit 99.1 reporting Q2 2026 financial results for the quarter ended June 30, 2026, including pro forma and non-GAAP metrics.

Company-level read

Ticker impact

$XBPBullishMedium confidence
Context

XBP reported Q2 2026 results with revenue down 14% YoY, net loss of $16.7M, and raised annualized AI efficiency target to $65-$75M.

Expected impact

Moderate upside bias on any market focus on margin/EBITDA trajectory, partially offset by the reported net loss and revenue contraction.

Evidence & confidence

The filing provides multiple fresh datapoints: Normalized EBITDA $21.9M (+8.4% YoY), adjusted gross margin record 24.9% (+290 bps YoY), and a higher annualized efficiency target with an in-year $35M benefit. However, revenue fell and net loss was reported, limiting conviction on immediate earnings power.

Market effects

Reinforces demand for on-premise, data-sovereign automation in regulated verticals like healthcare, while highlighting volatility in public sector timing.

No clear regional read-through beyond the company’s stated on-premise focus.

Limited; the disclosure is company-specific with no stated cross-border regulatory or macro shock.

Counterpoint

The raised efficiency target may not fully offset the underlying revenue contraction, and net loss suggests cash earnings quality still needs validation.

Key entities

  • XBP Global Holdings, Inc.

    Reported Q2 2026 revenue, margins, net loss, Normalized EBITDA, contract value metrics, and raised AI-led efficiency guidance.

  • Andrej Jonovic

    CEO quoted on profitability improvement and the raised annualized efficiency target.

  • Dejan Avramovic

    CFO scheduled to host the Aug 13 earnings call.

Related articles

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.